Exposure data
(ii) Exposure data. These shall be tabulated and presented with mean values and measure of variability (e.g., standard deviation) and shall include: (A) Airflow rates through the inhalation equipment. (B) Temperature and humidity of air. (C) Nominal concentration (total amount of test substance fed into the inhalation equipment divided by volume of air). (D) Actual concentration in test breathing zone. (E) Particle size distribution (e.g., median aerodynamic diameter of particles with standard deviation from the mean). (iii) Group animal data. Tabulation of toxic response data by species, strain, sex, and exposure level for: (A) Number of animals dying. (B) Number of animals showing signs of toxicity. (C) Number of animals exposed. (iv) Individual animal data. (A) Date of death during the study or whether animals survived to termination. (B) Date of observation of each abnormal sign and its subsequent course. (C) Body weight data. (D) Feed consumption data when collected. (E) Hematological tests employed and all results. (F) Clinical biochemistry tests employed and all results. (G) Necropsy findings. (H) Detailed description of all histopathological findings. (I) Statistical treatment of results where appropriate.